Skip to menu Skip to content Skip to footer

2019

Book Chapter

Primary aldosteronism; epidemiology and screening

Stowasser, Michael (2019). Primary aldosteronism; epidemiology and screening. Encyclopedia of endocrine diseases. (pp. 598-606) edited by Ilpo Huhtaniemi and Luciano Martini. Amsterdam, Netherlands: Elsevier. doi: 10.1016/B978-0-12-801238-3.64331-3

Primary aldosteronism; epidemiology and screening

2018

Journal Article

Aldosterone LC-MS/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism

Guo, Zeng, Poglitsch, Marko, McWhinney, Brett C., Ungerer, Jacobus P. J., Ahmed, Ashraf H., Gordon, Richard D., Wolley, Martin and Stowasser, Michael (2018). Aldosterone LC-MS/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism. Journal of Clinical Endocrinology and Metabolism, 103 (11), 3965-3973. doi: 10.1210/jc.2018-01041

Aldosterone LC-MS/MS assay-specific threshold values in screening and confirmatory testing for primary aldosteronism

2018

Conference Publication

Seated saline suppression testing for the diagnosis of primary aldosteronism - a validation study

Stowasser, Michael, Ahmed, Ashraf, Cowley, Diane, Wolley, Martin, McWhinney, Brett, Ungerer, Jacobus and Gordon, Richard (2018). Seated saline suppression testing for the diagnosis of primary aldosteronism - a validation study. 27th Scientific Meeting of the International Society of Hypertension, Beijing, China, 20-23 September 2018. London, United Kingdom: Lippincott Williams & Wilkins. doi: 10.1097/01.hjh.0000548518.71284.fd

Seated saline suppression testing for the diagnosis of primary aldosteronism - a validation study

2018

Journal Article

Cellular and genetic causes of idiopathic hyperaldosteronism

Omata, Kei, Satoh, Fumitoshi, Morimoto, Ryo, Ito, Sadayoshi, Yamazaki, Yuto, Nakamura, Yasuhiro, Anand, Sharath K., Guo, Zeng, Stowasser, Michael, Sasano, Hironobu, Tomlins, Scott A. and Rainey, William E. (2018). Cellular and genetic causes of idiopathic hyperaldosteronism. Hypertension, 72 (4), 874-880. doi: 10.1161/HYPERTENSIONAHA.118.11086

Cellular and genetic causes of idiopathic hyperaldosteronism

2018

Conference Publication

Application of a novel equilibrium angiotensin II assay in screening and confirmatory testing for primary aldosteronism: a pilot study

Guo, Zeng, Poglitsch, Marko, McWhinney, Brett, Ungerer, Jacobus, Ahmed, Ashraf H., Gordon, Richard, Wolley, Martin and Stowasser, Michael (2018). Application of a novel equilibrium angiotensin II assay in screening and confirmatory testing for primary aldosteronism: a pilot study. 27th Scientific Meeting of the International Society of Hypertension, Beijing, China, 20-23 September 2018. London, United Kingdom: Lippincott Williams & Wilkins. doi: 10.1097/01.hjh.0000548484.50709.9a

Application of a novel equilibrium angiotensin II assay in screening and confirmatory testing for primary aldosteronism: a pilot study

2018

Conference Publication

Variations in abundance of urinary exosomal renal sodium transporters in response to mineralocorticoid administration and oral salt loading and in relation to baseline plasma aldosterone and potassium

Wu, Aihua, Wolley, Martin, Xu, Shengxin, Gordon, Richard, Fenton, Robert and Stowasser, Michael (2018). Variations in abundance of urinary exosomal renal sodium transporters in response to mineralocorticoid administration and oral salt loading and in relation to baseline plasma aldosterone and potassium. 27th Scientific Meeting of the International Society of Hypertension, Beijing, China, 20-23 September 2018. Philadelphia, PA United States: Lippincott Williams & Wilkins. doi: 10.1097/01.hjh.0000548130.69597.05

Variations in abundance of urinary exosomal renal sodium transporters in response to mineralocorticoid administration and oral salt loading and in relation to baseline plasma aldosterone and potassium

2018

Journal Article

Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism

Stowasser, Michael, Ahmed, Ashraf H., Cowley, Diane, Wolley, Martin, Guo, Zeng, McWhinney, Brett C., Ungerer, Jacobus P. and Gordon, Richard D. (2018). Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism. The Journal of Clinical Endocrinology and Metabolism, 103 (11), 4113-4124. doi: 10.1210/jc.2018-01394

Comparison of seated with recumbent saline suppression testing for the diagnosis of primary aldosteronism

2018

Journal Article

A young man with severe hypertension

Tan, Jin Ern, Wu, Danielle and Stowasser, Michael (2018). A young man with severe hypertension. BMJ, 362 k2935, k2935. doi: 10.1136/bmj.k2935

A young man with severe hypertension

2018

Journal Article

Is it time to screen all patients with hypertension for primary aldosteronism?

Yang, Jun, Fuller, Peter J. and Stowasser, Michael (2018). Is it time to screen all patients with hypertension for primary aldosteronism?. Medical Journal of Australia, 209 (2), 57-59. doi: 10.5694/mja17.00783

Is it time to screen all patients with hypertension for primary aldosteronism?

2018

Journal Article

Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism

Williams, Tracy A., Burrello, Jacopo, Sechi, Leonardo A., Fardella, Carlos E., Matrozova, Joanna, Adolf, Christian, Baudrand, René, Bernardi, Stella, Beuschlein, Felix, Catena, Cristiana, Doumas, Michalis, Fallo, Francesco, Giacchetti, Gilberta, Heinrich, Daniel A., Saint-Hilary, Gaëlle, Jansen, Pieter M., Januszewicz, Andrzej, Kocjan, Tomaz, Nishikawa, Tetsuo, Quinkler, Marcus, Satoh, Fumitoshi, Umakoshi, Hironobu, Widimský, Jiří, Hahner, Stefanie, Douma, Stella, Stowasser, Michael, Mulatero, Paolo and Reincke, Martin (2018). Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism. Hypertension, 72 (3), HYPERTENSIONAHA.118.11382-649. doi: 10.1161/HYPERTENSIONAHA.118.11382

Computed tomography and adrenal venous sampling in the diagnosis of unilateral primary aldosteronism

2018

Conference Publication

Effect of mineralocorticoid blockade on human brown fat-a randomised placebo-controlled cross-over study

Thuzar, Moe, Law, W. Phillip, Dimeski, Goce, Stowasser, Michael and Ho, Ken K. Y. (2018). Effect of mineralocorticoid blockade on human brown fat-a randomised placebo-controlled cross-over study. Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB), Perth Australia, Aug 27-30, 2017. HOBOKEN: WILEY.

Effect of mineralocorticoid blockade on human brown fat-a randomised placebo-controlled cross-over study

2018

Conference Publication

Two for the price of one: unravelling a complex case of resistant hypertension

Jansen, Pieter M., Malasingam, Roshini, Wood, Simon T. and Stowasser, Michael (2018). Two for the price of one: unravelling a complex case of resistant hypertension. Joint Annual Scientific Meetings of Endocrine-Society-of-Australia (ESA) and Society-for-Reproductive-Biology (SRB), Perth, WA Australia, 27-30 August 2017. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.

Two for the price of one: unravelling a complex case of resistant hypertension

2018

Conference Publication

Application of a novel equilibrium angiotensin II assay in screening and confirmatory testing for primary aldosteronism: a pilot study

Guo, Z., Poglitsch, M., Mcwhinney, B., Ungerer, J., Ahmed, A. H., Gordon, R. D., Wolley, M. and Stowasser, M. (2018). Application of a novel equilibrium angiotensin II assay in screening and confirmatory testing for primary aldosteronism: a pilot study. 28th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH), Barcelona, Spain, 8-11 June 2018. London, United Kingdom: Lippincott Williams & Wilkins. doi: 10.1097/01.hjh.0000539884.36949.24

Application of a novel equilibrium angiotensin II assay in screening and confirmatory testing for primary aldosteronism: a pilot study

2018

Journal Article

CLCN2 chloride channel mutations in familial hyperaldosteronism type II

Scholl, Ute I., Stölting, Gabriel, Schewe, Julia, Thiel, Anne, Tan, Hua, Nelson-Williams, Carol, Vichot, Alfred A., Jin, Sheng Chih, Loring, Erin, Untiet, Verena, Yoo, Taekyeong, Choi, Jungmin, Xu, Shengxin, Wu, Aihua, Kirchner, Marieluise, Mertins, Philipp, Rump, Lars C., Onder, Ali Mirza, Gamble, Cory, McKenney, Daniel, Lash, Robert W., Jones, Deborah P., Chune, Gary, Gagliardi, Priscila, Choi, Murim, Gordon, Richard, Stowasser, Michael, Fahlke, Christoph and Lifton, Richard P. (2018). CLCN2 chloride channel mutations in familial hyperaldosteronism type II. Nature Genetics, 50 (3), 1-6. doi: 10.1038/s41588-018-0048-5

CLCN2 chloride channel mutations in familial hyperaldosteronism type II

2018

Conference Publication

Cellular and genetic causes of idiopathic hyperaldosteronism

Omata, Kei, Morimoto, Ryo, Ito, Sadayoshi, Yamazaki, Yuto, Nakamura, Yasuhiro, Anand, Sharath, Guo, Zeng, Stowasser, Michael, Sasano, Hironobu, Tomlins, Scott, Rainey, William and Satoh, Fumitoshi (2018). Cellular and genetic causes of idiopathic hyperaldosteronism. 27th Scientific Meeting of the International Society of Hypertension, Beijing, China, 20-23 September 2018. London, United Kingdom: Lippincott Williams & Wilkins. doi: 10.1097/01.hjh.0000548292.79006.6d

Cellular and genetic causes of idiopathic hyperaldosteronism

2018

Conference Publication

Measurement of aldosterone: comparison of liquid chromatography-tandem mass spectrometry with radioimmunoassay in screening and confirmatory testing for primary aldosteronism

Guo, Zeng, Poglitsch, Marko, McWhinney, Brett, Ungerer, Jacobus, Ahmed, Ashraf H., Gordon, Richard, Wolley, Martin and Stowasser, Michael (2018). Measurement of aldosterone: comparison of liquid chromatography-tandem mass spectrometry with radioimmunoassay in screening and confirmatory testing for primary aldosteronism. 27th Scientific Meeting of the International Society of Hypertension, Beijing, China, 20-23 September 2018. London, United Kingdom: Lippincott Williams & Wilkins.

Measurement of aldosterone: comparison of liquid chromatography-tandem mass spectrometry with radioimmunoassay in screening and confirmatory testing for primary aldosteronism

2018

Conference Publication

Seated saline suppression testing for the diagnosis of primary aldosteronism. A validation study

Stowasser, M., Ahmed, A., Cowley, D., Wolley, M., Mcwhinney, B., Ungerer, J. and Gordon, R. D. (2018). Seated saline suppression testing for the diagnosis of primary aldosteronism. A validation study. 28th European Meeting of Hypertension and Cardiovascular Protection of the European-Society-of-Hypertension (ESH), Barcelona, Spain, 8-11 June 2018. London, United Kingdom: Lippincott Williams & Wilkins. doi: 10.1097/01.hjh.0000539345.38001.45

Seated saline suppression testing for the diagnosis of primary aldosteronism. A validation study

2017

Journal Article

ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II)

De Sousa, S. M. C., Stowasser, M., Feng, J., Schreiber, A. W., Wang, P., Hahn, C. N., Gordon, R. D., Torpy, D. J., Scott, H. S. and Gagliardi, L. (2017). ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II). Journal of Human Hypertension, 31 (12), 857-859. doi: 10.1038/jhh.2017.71

ARMC5 is not implicated in familial hyperaldosteronism type II (FH-II)

2017

Journal Article

The SPARTACUS Trial: Controversies and Unresolved Issues

Beuschlein, Felix, Mulatero, Paolo, Asbach, Evelyn, Monticone, Silvia, Catena, Cristiana, Sechi, Leonardo A and Stowasser, Michael (2017). The SPARTACUS Trial: Controversies and Unresolved Issues. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 49 (12), 936-942. doi: 10.1055/s-0043-120524

The SPARTACUS Trial: Controversies and Unresolved Issues

2017

Journal Article

Can Screening and Confirmatory Testing in the Management of Patients with Primary Aldosteronism be Improved?

Stowasser, Michael, Ahmed, Ashraf, Guo, Zeng, Wolley, Martin, Ungerer, Jacobus, McWhinney, Brett, Poglitsch, Marko and Gordon, Richard (2017). Can Screening and Confirmatory Testing in the Management of Patients with Primary Aldosteronism be Improved?. Hormone and Metabolic Research, 49 (12), 915-921. doi: 10.1055/s-0043-121468

Can Screening and Confirmatory Testing in the Management of Patients with Primary Aldosteronism be Improved?